Tirzepatide is a novel dual GIP and GLP-1 receptor agonist peptide currently under investigation for its potential metabolic benefits. As a research chemical, this compound demonstrates promising activity in glucose control and weight management studies.
The peptide is supplied as a white lyophilized powder with 99% purity, packaged in sterile vials for research use only. Proper storage at -20°C or below is recommended to maintain stability.
Researchers investigating metabolic disorders may find Tirzepatide particularly interesting due to its dual mechanism of action. The compound activates both GIP and GLP-1 receptors, potentially offering enhanced effects compared to single-receptor agonists.
For laboratory use only. Not for human consumption. Researchers should follow all applicable regulations and safety protocols when handling this material.
When considering where to buy Tirzepatide for research purposes, quality and purity should be primary concerns. Our product undergoes rigorous quality control testing to ensure consistent performance in research applications.